Format

Send to

Choose Destination
Leg Med (Tokyo). 2013 Nov;15(6):335-7. doi: 10.1016/j.legalmed.2013.08.004. Epub 2013 Sep 10.

Neutrality of miniSTR D22S1045 marker by Ewing's sarcoma phenotype.

Author information

1
Laboratory of Molecular and Human Genetics, Faculty of Biosciences, PUCRS, 90619-900 Porto Alegre, RS, Brazil.

Abstract

Neutrality investigations of markers with forensic use are important to see if a phenotypic trait is being expressed in relation to the alleles of the marker. MiniSTR marker D22S1045 (locus 22q12.3) is localized near the breakpoint region of the EWS gene (22q12.2), which leads to the development of Ewing's Sarcoma. Analyzing allele frequencies and linkage disequilibrium in Ewing's sarcoma patients and non-affected populations, we found that the marker mD22S1045 was neutral when related to Ewing's Sarcoma.

KEYWORDS:

Chromosome 22; Ewing’s sarcoma; Forensic markers; MiniSTR; mD22S1045

PMID:
24112992
DOI:
10.1016/j.legalmed.2013.08.004
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center